Andrea is Director of Analytical Operations at Ironwood Pharmaceuticals, Inc., where he focuses on developing robust analytical strategies aligned with regulatory and compliance expectations for a GLP-2 analogue. He has 13 years of experience in the pharmaceutical industry across biotech and large pharmaceutical companies, with roles spanning Quality Control and Analytical Development, building extensive expertise in small molecule and peptide analytics within regulated environments.